Details for Patent: 11,730,725
✉ Email this page to a colleague
Which drugs does patent 11,730,725 protect, and when does it expire?
Patent 11,730,725 protects ZEJULA and is included in one NDA.
This patent has eighteen patent family members in sixteen countries.
Drugs Protected by US Patent 11,730,725
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ZEJULA | niraparib tosylate | TABLET;ORAL | 214876-001 | Apr 26, 2023 | RX | Yes | No | 11,730,725 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Glaxosmithkline | ZEJULA | niraparib tosylate | TABLET;ORAL | 214876-002 | Apr 26, 2023 | RX | Yes | No | 11,730,725 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Glaxosmithkline | ZEJULA | niraparib tosylate | TABLET;ORAL | 214876-003 | Apr 26, 2023 | RX | Yes | Yes | 11,730,725 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,730,725
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018341479 | ⤷ Subscribe | |||
| Australia | 2022200520 | ⤷ Subscribe | |||
| Brazil | 112020006039 | ⤷ Subscribe | |||
| Canada | 3076907 | ⤷ Subscribe | |||
| Chile | 2020000747 | ⤷ Subscribe | |||
| China | 111278433 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
